{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Gimeracil",
  "nciThesaurus": {
    "casRegistry": "103766-25-2",
    "chebiId": "",
    "chemicalFormula": "C5H4ClNO2",
    "definition": "A pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines.",
    "fdaUniiCode": "UA8SE1325T",
    "identifier": "C2416",
    "preferredName": "Gimeracil",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2019"
    ],
    "synonyms": [
      "5-Chloro-2,4-pyridinediol",
      "CDHP",
      "Chlorodihydroxypyridine",
      "GIMERACIL",
      "Gimeracil"
    ]
  }
}